An Army infantry veteran in his early 40s arrived at Valor Spine with a two-level lumbar fusion recommendation after 12 years of service that included combat deployments and airborne operations. Following biologic disc repair at both symptomatic levels and 12 weeks of structured rehabilitation, his pain score fell from 8 to 2 on a 10-point scale, he returned to running and strength training, and he avoided lumbar fusion entirely. Individual outcomes vary; a clinical evaluation is the only way to know whether this approach is appropriate for a given patient.
Illustrative Case Snapshot
This is a composite illustrative scenario drawn from the patterns our clinical staff observes. It does not represent a single identified patient. All identifying details have been generalized to protect patient privacy.
- Patient profile: Anonymized male Army infantry veteran, early 40s, 12 years of service, multiple combat deployments and airborne operations
- Diagnosis: Symptomatic annular tears at L4-L5 and L5-S1 with degenerative disc disease confirmed on MRI
- Goals: Avoid lumbar fusion, return to running and strength training, eliminate long-term opioid use
- Approach: Intra-annular fibrin injection at both symptomatic levels followed by 12 weeks of progressive rehabilitation
- 24-month outcomes: Self-reported pain 8 → 2, full return to physical training, no surgery, no chronic opioid prescriptions
Who Is This Veteran, and Why Did He Come to Valor?
The composite profile here reflects what the Valor team sees regularly among infantry veterans: someone in his early 40s whose spine absorbed 12 years of rucking with 60–80 pound loads, repeated hard landings during parachute operations, and the cumulative compression that defines a career in the infantry. By the time he sought evaluation, pain had been progressing for more than three years.
The epidemiology behind this profile is well documented. According to VA and VHA data, 65.6% of veterans report pain in the past three months. Low back pain is the number-one reason active-duty members seek medical care. Research on former military parachutists shows that the overwhelming majority develop lumbar disc degeneration on imaging. This patient was not an outlier — he was the pattern.
His daily pain registered at 7–8 out of 10, with spikes during prolonged sitting, lifting, and physical training. MRI showed annular tears at L4-L5 and L5-S1 with disc desiccation and modest height loss. There was no frank herniation requiring decompression and no neurological deficit on examination. A prior surgical consultation had recommended a two-level lumbar fusion at L4-S1.
For a veteran in his early 40s who wanted three to four more decades of active life, that recommendation warranted a second opinion. Published literature shows that back surgery carries roughly a 40% failure rate — a body of evidence sometimes described as Failed Back Surgery Syndrome — and that revision rates can exceed 20% within a decade. For this veteran, exploring a non-surgical path first was the clinically reasonable next step. Patients in similar situations often consider whether fusion is truly the only option.
Baseline Metrics at Intake
| Measure | Baseline Value |
|---|---|
| VAS pain (0–100 mm) | 78 mm (consistent with the 72.4 mm baseline reported in published fibrin outcome cohorts) |
| Self-reported pain (0–10) | 7–8 daily; 9 with provocation |
| Imaging findings | Annular tears at L4-L5 and L5-S1; degenerative disc disease; no herniation requiring decompression |
| Functional limitations | Unable to run; unable to lift more than 25 lb; sitting tolerance under 30 minutes |
| Prior treatments | Physical therapy (partial benefit), epidural steroid injections (transient relief), NSAIDs, episodic opioids |
| Surgical recommendation received | Two-level lumbar fusion (L4-S1) |
Why Did Biologic Disc Repair Fit This Veteran’s Profile?
The treatment goal was direct: address the actual pain generators — the annular tears — without eliminating segmental motion or introducing hardware.
Intra-annular fibrin injection is a biologic disc repair technique that delivers an FDA-approved fibrin sealant directly into the annular fissure under imaging guidance. The sealant is intended to seal the tear, reduce inflammatory leakage onto surrounding nerve tissue, and create a biologic scaffold that supports the disc’s own healing response. The procedure preserves disc height and segmental motion. It involves no incisions and is performed under local anesthesia or light sedation, typically in under an hour.
Published long-term outcome data on this approach show VAS pain scores improving from a baseline of 72.4 mm to 33.0 mm at 104 weeks. Among the most-tracked cohorts — more than 7,000 procedures with long-term follow-up — the reported success rate is 83%; individual outcomes vary. Patient satisfaction at two or more years of follow-up has been reported at 70%. For patients who had previously undergone spine surgery without adequate relief, 80% reported positive outcomes with the fibrin approach — again, individual outcomes vary and a clinical evaluation determines suitability.
The fibrin sealant used is manufactured by Baxter Pharmaceuticals and is FDA-approved as a sealant. Specific clinical applications, candidacy, and outcomes vary by patient.
For this veteran’s profile — annular tears confirmed on imaging, conservative care exhausted, no surgical emergency, strong motivation to preserve function — the intra-annular fibrin injection was a clinically appropriate option to evaluate. Patients facing similar decisions are also encouraged to read about how annular tear repair has worked for other service members.
What Did the Procedure and Recovery Timeline Look Like?
The approach followed the standard two-step process the Valor team uses for candidates at multiple disc levels.
Step 1 — Annulogram: Before any treatment, an imaging-guided diagnostic annulogram was performed to identify every tear and leakage point at L4-L5 and L5-S1. This step is not optional — it defines exactly which tears need to be addressed and confirms the disc levels responsible for the patient’s pain. Treating without it means guessing.
Step 2 — Fibrin Injection: With the annulogram confirming two symptomatic levels, the clinical team performed the intra-annular fibrin injection at both L4-L5 and L5-S1 in a single procedure session. A thin catheter was guided under imaging into the annular fissure at each level, and the FDA-approved fibrin sealant was delivered precisely into the tear. Total procedure time was under one hour. The veteran went home the same day.
Weeks 1–4: Activity restrictions were in place. Light walking was encouraged; high-impact loading was avoided to allow the sealant to integrate.
Weeks 5–12: Progressive rehabilitation was introduced — core stabilization, controlled loading, and gradual return to functional movement. Pain scores tracked downward throughout this phase.
Months 3–24: The veteran returned to running and structured strength training. At the 24-month follow-up, self-reported pain held at 2 out of 10. No surgery was performed. No chronic opioid prescriptions were issued.
Clinical Note
What the Valor team observes repeatedly with veteran patients like this one is that the fusion recommendation — while sometimes clinically appropriate — arrives before the patient has had a real conversation about what the tear itself can tolerate. Infantry veterans in their early 40s have already paid an enormous physical cost. When the imaging shows annular tears without a neurological emergency, and when conservative care has been genuinely exhausted, it is worth pausing before accepting permanent hardware in the spine. That pause — and the evaluation that follows — is what this visit is designed to be. Not a guarantee of a different outcome. A real look at whether one exists.
What Were the 24-Month Outcomes?
Outcome tracking at Valor follows patients through the 24-month mark as a standard. For this illustrative profile, the results at each interval are summarized below. Individual outcomes vary; these figures reflect one composite case consistent with published cohort data.
| Timepoint | Self-Reported Pain (0–10) | Functional Milestone |
|---|---|---|
| Baseline | 7–8 | Unable to run or lift; sitting tolerance <30 min |
| 6 weeks | 5–6 | Walking without pain spikes; seated tolerance improving |
| 12 weeks | 3–4 | Resumed light strength training; jogging initiated |
| 6 months | 2–3 | Running 3x/week; lifting at pre-injury loads |
| 24 months | 2 | Full physical training; no surgery; no chronic opioids |
The 24-month VAS trajectory in this composite case aligns closely with the published peer-reviewed data showing VAS improvement from 72.4 mm at baseline to 33.0 mm at 104 weeks across larger fibrin cohorts. The Valor team does not present this alignment as a guarantee — it is presented as evidence that this composite outcome is plausible and grounded in population-level data.
Does the Mission Act Cover This Procedure for Veterans?
For veterans whose VA facility cannot provide timely or appropriate care for their disc condition, biologic disc repair may be a covered VA benefit under the Mission Act. VA coverage is determined case-by-case under Mission Act criteria by the VA, not by Valor Spine. Valor coordinates the referral process directly with VA referral coordinators — the veteran does not have to navigate the VA system alone.
What Valor handles on the veteran’s behalf includes Mission Act eligibility documentation, coordination with VA referral coordinators, and logistical support for procedure travel and, where approved, accompanying-caregiver travel. Veterans interested in whether this pathway applies to their situation are encouraged to request a consultation. The Valor team has direct experience working through VA referral channels for patients in exactly this profile. More on how that process works is available in the Veterans Regenerative Spine Care and Insurance FAQ.
Veterans who have already attempted surgery without adequate relief and are now exploring next steps may also find it useful to review how non-surgical recovery has worked after a failed first surgery.
Who Is a Candidate for This Approach?
A clinical evaluation is the only way to know for certain. The profile that fits this illustrative case — and the broader candidacy pattern the Valor team evaluates — typically includes the following:
- Chronic back or neck pain attributed to disc pathology confirmed on MRI
- Annular tears identified on imaging or diagnostic annulogram
- Conservative care genuinely exhausted (physical therapy, injections, medications) without lasting resolution
- No neurological emergency requiring urgent surgical intervention
- A preference to preserve segmental motion and avoid hardware
- For veterans: VA care that has not resolved the condition, triggering potential Mission Act eligibility
For patients who have been told fusion is the next step but are not ready to accept that recommendation without exploring alternatives, a consultation with the Valor team is the logical next step. The evaluation process begins with a review of existing MRI findings — at no cost — before any further diagnostic steps are recommended. Patients curious about similar outcomes from other non-surgical cases may find the Marine veteran non-surgical case study a useful reference.
Frequently Asked Questions
Is biologic disc repair appropriate for two-level lumbar disc disease?
For patients with annular tears confirmed at multiple levels, the fibrin procedure can be performed at more than one disc level in a single session. Candidacy depends on the specific tear pattern, disc condition, and overall clinical picture — a clinical evaluation is the only way to know for certain.
The composite case documented here involved two symptomatic levels (L4-L5 and L5-S1). The annulogram confirmed tears at both levels before treatment was initiated. Treating multiple levels simultaneously is part of the standard approach when imaging supports it, and the 24-month outcome in this profile showed sustained pain reduction without additional intervention.
How does this procedure compare to lumbar fusion?
Intra-annular fibrin injection is a non-surgical alternative that addresses the tear directly without eliminating segmental motion or introducing hardware. Lumbar fusion permanently immobilizes the treated segment. Back surgery carries roughly a 40% failure rate in published literature; individual outcomes vary with either approach.
The fibrin procedure is not superior to fusion in every clinical situation. Patients with neurological emergencies, spinal instability, or other structural conditions may require surgery. The distinction matters: for patients whose pain originates from annular tears without a surgical emergency, the fibrin approach is a clinically distinct option — not simply a delay tactic before inevitable surgery.
Can veterans access this procedure through the VA?
Biologic disc repair may be a covered VA benefit under the Mission Act when the VA cannot provide timely or appropriate care. VA coverage is determined case-by-case by the VA, not by Valor Spine.
Valor coordinates directly with VA referral coordinators and handles the Mission Act documentation process on the veteran’s behalf. Veterans do not need to navigate the referral system independently. The first step is a consultation to assess clinical candidacy and determine whether Mission Act eligibility applies.
What is an annulogram and why is it done before the procedure?
An annulogram is an imaging-guided diagnostic that identifies exactly which discs are torn and leaking before any treatment is delivered. It is a required step — not optional — because it defines the treatment targets precisely.
Treating annular tears without a prior annulogram means treating based on MRI inference rather than confirmed tear mapping. The annulogram eliminates that ambiguity. It is performed before the fibrin injection and its findings directly guide how many levels are treated and where the sealant is delivered.
How long does recovery take before returning to physical training?
For patients whose occupation or lifestyle demands high physical output — including military veterans — the typical progression in published outcome data involves meaningful pain reduction by 12 weeks, with return to structured physical training in the 3–6 month window. Individual timelines vary based on the number of levels treated, the severity of the tears, and adherence to rehabilitation protocols.
In the composite case documented here, the veteran resumed running by month three and was training at pre-injury loads by six months. No absolute timeline guarantee applies — a clinical evaluation and post-procedure rehabilitation plan will reflect the individual patient’s anatomy and goals.
What happens if the procedure does not provide adequate relief?
The fibrin procedure does not close off surgical options. Patients who do not achieve adequate relief retain the ability to pursue additional conservative care, repeat evaluation, or surgical consultation. The procedure involves no incisions and introduces no hardware that would complicate subsequent treatment decisions.
Among the most-tracked outcomes in published data — over 7,000 procedures with long-term follow-up — the reported success rate is 83%; individual outcomes vary. For patients who have already undergone spine surgery without resolution, 80% reported positive outcomes with the fibrin approach in outcome registry data. Individual outcomes vary and a clinical evaluation determines suitability.
This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you. The fibrin sealant used in the procedure is FDA-approved as a sealant. Specific clinical applications, candidacy, and outcomes vary by patient. VA coverage is determined case-by-case under Mission Act criteria by the VA, not by Valor Spine. Valor coordinates the referral process; the VA makes coverage decisions. The illustrative case presented in this post is a composite scenario drawn from clinical patterns and does not represent a single identified patient.
